Loading...
Cardiovascular Effects of Incretin Therapy in Diabetes Care
Diabetes patients are at high risk for development of cardiovascular disease. The cardiovascular safety of antidiabetic medications is a concern. Incretin therapies, including glucagon-like peptide 1 receptor (GLP-1) receptor agonists and dipeptidyl peptidase 4 (DPP-4) inhibitors, have recently been...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Mary Ann Liebert, Inc.
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4162447/ https://ncbi.nlm.nih.gov/pubmed/24842063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/met.2014.0035 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|